We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
125 hedge funds and large institutions have $299M invested in Lexicon Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 28 increasing their positions, 41 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
292% more call options, than puts
Call options by funds: $1.13M | Put options by funds: $289K
35% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 17
2% more funds holding
Funds holding: 123 → 125 (+2)
1.46% more ownership
Funds ownership: 70.21% → 71.66% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less capital invested
Capital invested by funds: $344M → $299M (-$44.9M)
32% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 41
Holders
125
Holders Change
+2
Holders Change %
+1.63%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
23
Increased
28
Reduced
41
Closed
17
Calls
$1.13M
Puts
$289K
Net Calls
+$844K
Net Calls Change
-$2.49M
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.65M |
| 2 |
Jane Street
New York
|
+$1.74M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$1.73M |
| 4 |
Millennium Management
New York
|
+$1.36M |
| 5 |
Goldman Sachs
New York
|
+$1.18M |
